![](/img/cover-not-exists.png)
PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting
J.G. Gay-Molina, R. Sánchez-Kobashi, E. Muciño-Ortega, C.I. Gutiérrez-Colín, R.M. Galindo-SuárezVolume:
15
Year:
2012
Language:
english
DOI:
10.1016/j.jval.2012.08.2113
File:
PDF, 60 KB
english, 2012